SynthesisBMC cancer2025

Cerebrospinal fluid Circulating Tumor DNA (ctDNA) as a biomarker for CNS metastases in Non-Small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis comparing CSF ctDNA and traditional methods.

Oluwatobi O Olayode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.